| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2153385 | Nuclear Medicine and Biology | 2015 | 8 Pages |
Abstract
18F-FDOPA PET appears to be a viable radiopharmaceutical for the diagnosis and treatment planning of gliomas cases, improving on that of MRI and 18F-FDG PET.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christopher Bell, Nicholas Dowson, Simon Puttick, Yaniv Gal, Paul Thomas, Mike Fay, Jye Smith, Stephen Rose,